IRIS
CRIMI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.079
AS - Asia 1.544
EU - Europa 915
SA - Sud America 332
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.038
SG - Singapore 865
IT - Italia 447
CN - Cina 425
BR - Brasile 303
IE - Irlanda 233
KR - Corea 121
CI - Costa d'Avorio 96
IN - India 47
RU - Federazione Russa 43
SN - Senegal 42
FI - Finlandia 31
CA - Canada 28
GB - Regno Unito 28
DE - Germania 26
UA - Ucraina 24
NL - Olanda 20
FR - Francia 13
IQ - Iraq 12
NG - Nigeria 12
SE - Svezia 12
TR - Turchia 11
AT - Austria 10
VN - Vietnam 10
CO - Colombia 8
JP - Giappone 8
ES - Italia 7
PL - Polonia 7
AR - Argentina 6
MX - Messico 6
PK - Pakistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BD - Bangladesh 5
EC - Ecuador 4
ZA - Sudafrica 4
BE - Belgio 3
CH - Svizzera 3
HK - Hong Kong 3
JO - Giordania 3
MA - Marocco 3
NP - Nepal 3
EU - Europa 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
MC - Monaco 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 5.034
Salva come PNG Salva come JPEG
Città #
Santa Clara 756
Singapore 590
Hefei 254
Dublin 233
Chicago 191
Boardman 176
Seoul 121
Chandler 100
Abidjan 96
Ashburn 89
Catania 69
Civitanova Marche 66
Dakar 42
Los Angeles 42
Milan 39
Palermo 38
Jacksonville 33
Beijing 31
São Paulo 28
Lappeenranta 25
Pune 23
Lawrence 19
Seattle 19
Andover 18
Cambridge 18
Toronto 17
Des Moines 14
Nanjing 13
Abuja 12
Rome 12
Council Bluffs 11
Kochi 11
Rio de Janeiro 11
Naples 10
Bremen 9
Dong Ket 9
Giarre 9
Phoenix 8
Reggio Emilia 8
Salvador 8
Wilmington 8
Belo Horizonte 7
Brasília 7
Munich 7
Shenyang 7
Tokyo 7
Amsterdam 6
Assago 6
Campinas 6
Corbetta 6
Gravina di Catania 6
New York 6
San Francisco 6
Abbiategrasso 5
Amiens 5
Bologna 5
Brooklyn 5
Helsinki 5
Mumbai 5
Nanchang 5
Warsaw 5
Atlanta 4
Fortaleza 4
Grafing 4
London 4
Madrid 4
Manchester 4
Mascali 4
Paris 4
Porto Alegre 4
Praia Grande 4
Ribeirão Preto 4
Rimini 4
São José dos Campos 4
Ankara 3
Brussels 3
Cesa 3
Chennai 3
Columbus 3
Dhaka 3
Dordrecht 3
Gravina in Puglia 3
Hamilton 3
Hebei 3
Istanbul 3
Johannesburg 3
Lahore 3
Mascalucia 3
Messina 3
Mexico City 3
Pogliano Milanese 3
Saint Petersburg 3
San Mateo 3
Secaucus 3
Sorocaba 3
São Bernardo do Campo 3
Taizhou 3
The Dalles 3
Tianjin 3
Uberlândia 3
Totale 3.533
Salva come PNG Salva come JPEG
Nome #
Bronchodilator response as a marker of poor asthma control 77
Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer 76
Protective effect of Resveratrol on TGF-beta-induced lung fibroblast differentiation 75
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients 74
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction 72
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 70
Mutual Interaction Between Human Lung Fibroblasts And T LymphocyteS 69
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells 69
Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstructive pulmonary disease 69
Exhaled breath condensate cysteinyl leukotrienes (cys-LTs) in gastroesophageal reflux disease-related asthma 68
Rugarli. Medicina interna sistematica 67
Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report 66
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics 62
Point-of-care blood eosinophil count in a severe asthma clinic setting 57
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 56
Resumption of respiratory outpatient services in the COVID-19 era: Experience from Southern Italy 54
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies 53
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 53
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 51
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 50
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 50
Is the Power Spectrum of Electromyography Signal a Feasible Tool to Estimate Muscle Fiber Composition in Patients with COPD? 50
Bronchial reversibility testing: an index of poorly controlled asthma 48
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 47
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 47
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux 47
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 45
Impact of chronic obstructive pulmonary disease on passive viscoelastic components of the musculoarticular system 45
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 44
Tezepelumab for asthma 44
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 42
Prolonged respiratory failure: when doctor and family connect, the patient wins 41
Diastolic Function and Positive Airway Pressure: More Research Is Warranted 41
Impact of asthma on bronchiectasis severity and risk of exacerbations 41
Diagnostic delay in bronchiectasis: an Italian perspective 40
Intermittent abdominal pressure ventilation management in neuromuscular diseases: a Delphi panel Consensus 39
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 38
Adherence to omalizumab: A multicenter "real-world" study 38
Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma 37
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 37
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 37
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 37
Asthma severity: the patient’s point of view 36
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression 36
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 36
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 35
Anti-inflammatory role of vitamin D in muscle dysfunctions of patients with chronic obstructive pulmonary disease: a comprehensive review 35
Airway hyperresponsiveness with chest strapping: A matter of heterogeneity or reduced lung volume? 35
Personalized Medicine in Asthma: Current Approach and Future Perspectives 34
Continuous vs intermittent Non-Invasive blood pressure MONitoring in preventing postoperative organ failure (niMON): study protocol for an open-label, multicenter randomized trial 34
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma 34
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients 33
Comparability of asthma control test scores between self and physician-administered test 33
Performance of EasyBreath Decathlon Snorkeling mask for delivering continuous positive airway pressure 33
Domiciliary Non-invasive Ventilation in COPD: An International Survey of Indications and Practices 33
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 33
High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study 33
Effects of high-flow nasal therapy on swallowing function: a scoping review 32
Secretion management in patients with ineffective airway clearance with non-invasive mechanical ventilation use: Expert guidance for clinical practice 32
Are we overlooking the lung function in the definition of severe asthma remission? 32
A Key to Unlocking the Mysteries of COVID-19 Pulmonary Sequelae: Are We There? 32
Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections 32
Long-term home noninvasive ventilation (LTHNIV) in restrictive thoracic diseases: The Italian snapshot 32
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study 32
European survey of domiciliary noninvasive ventilation (NIV) in severe COPD patients: the Italian practices 32
Fully covered self-expandable metal stent (SEMS) in tracheo-bronchial disorders: clinical experience 31
A European survey of Non- Invasive Ventilation (NIV) 31
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask 31
Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma 31
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab 31
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis 31
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 31
A new gambler at the table of management of COVID-19 associated acute respiratory failure. Changing position to do it better? 31
Bronchiectasis and asthma: a dangerous liaison? 31
REINVENT: ERS International survey on REstrictive thoracic diseases IN long term home noninvasive VENTilation 30
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma 30
Novel Biological Therapies for Severe Asthma Endotypes 30
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 30
Biologics in severe asthma 30
Switching Biological Therapies in Severe Asthma 30
Home High Flow Nasal Therapy for Patients at End of Life: Benefits, Hopes, and Goals of Care 30
Effect of Laboratory Testing Guidelines on the Utilization of Tests and Order Entries in a Surgical Intensive Care Unit 29
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers 29
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 29
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 29
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use 29
The influence of policies limiting author self-citations on journals impact factor and self-citation rate in respiratory system 29
Uneven use of noninvasive ventilation in acute respiratory failure in Europe 28
Airway hyperresponsiveness with chest strapping: effects of heterogeneity and reduced lung volume 28
Ultrasound-guided placement of long peripheral cannula in children with cystic fibrosis 28
High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future 28
Noninvasive Ventilation for Weaning and Post-Extubation Failure 28
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 28
Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate 27
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 27
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study 27
High flow nasal therapy in Acute Exacerbation of COPD: Ready for the prime time? 27
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension 26
Noninvasive continuous arterial pressure monitoring with Clearsight during awake carotid endarterectomy: A prospective observational study 26
Comment on Liu et al. Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life 2022, 12, 1419 26
Totale 4.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.049
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 3 11 3 19 5 9 0 7 18 9 10
2021/2022126 12 20 0 2 17 0 20 2 14 2 3 34
2022/2023635 19 11 8 44 23 50 49 115 249 19 19 29
2023/2024690 24 78 40 59 29 125 16 69 7 34 135 74
2024/20253.402 69 454 223 109 616 373 131 83 229 304 307 504
2025/2026170 170 0 0 0 0 0 0 0 0 0 0 0
Totale 5.226